fbpx
CBD & Hemp Emarketplace
1 minute reading time (81 words)

Australia expedites review of medical cannabis product Epidiolex

Australia expedites review of medical cannabis product Epidiolex

The only medical cannabis product in the Australian Register of Therapeutic Goods might soon be joined by another. Australian health regulators quietly gave Epidiolex, a cannabidiol medication, orphan designation and priority review status in late 2019. The designations allow the Therapeutic Goods Administration to wave application and evaluation fees, as well as expediting its assessment […]

Australia expedites review of medical cannabis product Epidiolex is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

By accepting you will be accessing a service provided by a third-party external to https://www.hemptalk.com/